Home
Bain Capital Life Sciences Fund II reported a 9.99% stake in Xilio Therapeutics XLO · 664,021 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 9.99%
- Last report
- 8.5% · filed 26/02/17
- Shares held
- 664,021 sh
- Class
- Common Stock, par value $0.0001 per share
- Event date
- 26/03/31
- Filed
- 26/05/15
9.99% stake · +1.5pp from the last report
- Stake
- 9.99%
- Last report
- 8.5%
- Since last report
- +1.5pp
Xilio Therapeutics trades, last 26 weeks
What else happened in Xilio Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Bain Capital Life Sciences Fund II's other 5% stake reports
- Bain Capital Life Sciences Fund II
5% stakeC4 Therapeutics
5% stakeC4 Therapeutics
CCCC
6.25% stake
6,060,000 sh
6.25% stake
Filed 25/10/24
- Bain Capital Life Sciences Fund II
5% stakeSavara
5% stakeSavara
SVRA
9.99% stake
17,600,621 sh
9.99% stake
Filed 25/03/27
